RAC 0.80% $1.86 race oncology ltd

[WEBINAR REPLAY] What it takes to get a new drug to market in Australia, page-26

  1. 145 Posts.
    lightbulb Created with Sketch. 642
    Do you think the only thing that will generate an increase in the share price is approval?

    I think you need to take a step back and think critically about what that comment from DT means. Nobody here is under the illusion that bisantrene approval is imminent. Even with accelerated approval at the end of P2 it's probably 5 years away.

    There are about 30 milestones in between now and that point that should meaningfully increase the share price.

    I really don't think biotech is for you if you don't have any patience
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.86
Change
-0.015(0.80%)
Mkt cap ! $316.8M
Open High Low Value Volume
$1.88 $1.88 $1.79 $163.0K 89.00K

Buyers (Bids)

No. Vol. Price($)
2 34299 $1.84
 

Sellers (Offers)

Price($) Vol. No.
$1.86 3635 1
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.